Christine Siu, CFO and Secretary at Eidos Therapeutics, Inc. (EIDX), sold 33,700 shares at $29.34 ($1.0M) on 2019-06-05, disclosed to the SEC on 2019-06-07.
Open-market sale of $1.0M EIDX by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.34 | 3,279 | $96K | 9.5% |
| 2 | $29.34 | 3,279 | $96K | 9.5% |
| 3 | $30.10 | 13,421 | $404K | 40.0% |
| 4 | $30.10 | 13,421 | $404K | 40.0% |
| 5 | $31.03 | 300 | $9K | 0.9% |
| Total | $29.96 avg | 33,700 |
| $1.0M |
| 100% |
| Filing → |
| EIDX | SELL | 2019-11-22 | $2.5M | — | Filing → |
| EIDX | SELL | 2019-07-12 | $197K | — | Filing → |
| EIDX | SELL | 2019-04-26 | $131K | — | Filing → |